APOE and Alzheimer disease: To date, APOE continues to be recognized as a significant genetic risk factor for late‐onset AD, contributing to the disruption of large‐scale dynamic between‐network connectivity, hindering information exchange between networks, and ultimately leading to abnormalities of CSF biomarkers and cognitive decline.